ALTH12-1:4
AssetSmall molecule
Antioxidant and anti-inflammatory formulation for ulcerative colitis
- Stage
- Phase 1
- Modality
- Small molecule
- Target
- Oxidative stress and ROS signalling
- Indications
- 1
- Trials
- 288
- Developers
- 1
Indications
1Ulcerative colitis
Phase 1COMPLETEDNCT01020708clinicaltrials.gov7 Oct 2026
- Targets and what it contains3
- Owner and partners1
- Trials288
- Evidence for its targets3
- Competitors2
- Aging relevance1
- Signals15
Every asset’s record: target, stage, trials and the evidence behind it.
See ProUpdated 7 Oct 2026 · 2 sources